Advertisement

End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF)

  • Avi DorEmail author
  • Mark V. Pauly
  • Margaret A. Eichleay
  • Philip J. Held
Article

Abstract

End-stage renal disease (ESRD) is a debilitating, costly, and increasingly common condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with alternative models of incentives and benefits, collected under the International Study of Health Care Organization and Financing, a substudy within the Dialysis Outcomes and Practice Patterns Study. Variation in spending per ESRD patient is relatively small, but correlated with overall per capita health care spending. Remaining differences in costs and outcomes do not seem strongly linked to differences in incentives.

Keywords

End-stage renal disease Dialysis Health care financing Incentives Medical costs Reimbursement Transplantation 

JEL Classifications

I10 I11 I12 I18 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ansell D., Feest T. (1999). UK Renal Registry Report 1999. Bristol, The Renal AssociationGoogle Scholar
  2. Ansell D., Feest T., Byrne C., Ahmad A. (2003). UK Renal Registry Report 2003. Bristol, The Renal AssociationGoogle Scholar
  3. Aron D.C., Harper D.L., Shepardson L.B., Rosenthal G.E. (1998). Impact of risk-adjusting cesarean delivery rates when reporting hospital performance. Journal of the American Medical Association, 279(24): 1968–1972CrossRefGoogle Scholar
  4. Ashton, T., & Marshall, M. R. (2007). The organization and financing of dialysis and kidney transplantation services in New Zealand. International Journal of Health Care Finance and Economics. DOI:  10.1007/s10754-007-9023-x
  5. Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) (2005). Registry Report. Adelaide: ANZDATA.Google Scholar
  6. Birkmeyer J.D., Sharp S.M., Finlayson S.R., Fisher E.S., Wennberg J.E. (1998). Variation profiles of common surgical procedures. Surgery, 124, 917–923Google Scholar
  7. Birkmeyer J.D., Siewers A.E., Finlayson E.V.A., Stukel T.A., Lucas F.L., Batista I., Welch H.G., Wennberg D.E. (2002). Hospital volume and surgical mortality in the United States. New England Journal of Medicine, 346, 1128–1137CrossRefGoogle Scholar
  8. Brooks J.M., Irwin C.P., Hunsicker L.G., Flanigan M.J., Chrischilles E.A., Pendergast J.F. (2006). Effect of dialysis center profit-status on patient survival: A comparison of risk-adjustment and instrumental variable approaches. Health Services Research, 41(6): 2267–2289CrossRefGoogle Scholar
  9. Canadian Organ Replacement Register (2005). Treatment of end-stage organ failure in Canada 2002 and 2003. Ottawa: Canadian Institute for Health Information.Google Scholar
  10. Cass A., Chadban S., Craig J., Howard K., McDonald S., Salkeld G., White S. (2006). The economic impact of end stage kidney disease in Australia. Sydney, The George Institute for International HealthGoogle Scholar
  11. Ceballos M., Lopez-Revuelta K., Caracho R., Garcia Lopez F., Castro P., Gutierrez J.A., Martin-Martinez E., Alonso R., Bernabeu R., Lorenzo V., Arias M., Sierra T., Estebanez C., Lara M., Cleries M., Vela E., Garcia-Blasco M.J., Zurriaga O., Vazquez C., Sanchez-Casajus A., Rodado R., Ripio J., Asin J.L., Magaz A. (2005). Informe de diálisis y trasplante correspondiente al año 2002 de la Sociedad Española de Nefrología y Registros Autonómicos. Nefrologia, 25(2), 121–124, 126–129.Google Scholar
  12. Chalky M., Macomson J.H. (1998). Contracting for health services with unmonitored quality. The Economic Journal, 108(449): 1093–1110CrossRefGoogle Scholar
  13. Combe C., Pisoni R.L., Port F.K., Young E.W., Canaud B., Mapes D.L., Held P.J. (2001). Dialysis outcomes and practice patterns study: données sur l’utilisation des cathéters veineux centraux en hémodialyse chronique. Néphrologie, 22(8): 379–384Google Scholar
  14. Conte F. (2004). Registro Italiano di Dialisi e Trapianto. Esperienza 1996–2001. Giornale Italiano di Nefrologia, 6, 561–567Google Scholar
  15. Couchoud, C., Frimat, L., Aldigier, J. C., de Cornelissen, F., Dabot, C., Joyeuz, V., Labeeuw, M., Maheut, H., & Stengel, B. (2005). Incidence et évaluation des traitements de suppléance de l’insuffisance rénale chronique dans sept régions françaises en 2003. Bulletin Ėpidémiologique Hebdomadaire, 37–38, 188–190.Google Scholar
  16. Danovitch G.M., Cohen D.J., Weir M.R., Stock P.G., Bennett W.M., Christensen L.L., Sung R.S. (2005). Current status of kidney and pancreas transplantation in the United States, 1994–2003. American Journal of Transplantation, 5(4 Pt 2): 904–915CrossRefGoogle Scholar
  17. Danzon, P. M., & Furukawa, M. F. (2003). Prices and availability of pharmaceuticals: Evidence from nine countries. Health Affairs, Web exclusive (October 29, 2003)W3, 521–536.Google Scholar
  18. Dawson D. (1994). Costs and prices in the internal market: Markets versus the executive management guideline. York, Centre for Health Economics. Working Paper n. 115.Google Scholar
  19. De Negri A., Formica M., Cavagnino A. (1997). Valutazione dei costi dei trattamenti dialitici. Giornale Italiano di Nefrologia, 14, 325–329Google Scholar
  20. De Vecchi A.F., Dratwa M., Wiedemann M.E. (1999). Healthcare systems and end-stage renal disease (ESRD) therapies—an international review: Costs and reimbursement/funding of ESRD therapies. Nephrology Dialysis Transplantation, 14(Supp 6): 34–41Google Scholar
  21. Deutschen Arbeitsgemeinschaft für Klinische Nephrologie (DAGKN) (2006). Dialysestandard 2006. Mitteilungen für Klinische Nephrologie, XXXV. Retrieved December 28, 2006, at http://www.nephrologie.de/ Dialysestandar2006.pdfGoogle Scholar
  22. Dor A. (2004). Optimal price rules, administered prices and suboptimal prevention: Evidence from a Medicare program. Journal of Regulatory Economics, 25(1): 81–104CrossRefGoogle Scholar
  23. Durand-Zaleski, I., Combe, C., & Lang, P. (2007). International Study of Health Care Organization and Financing for end-stage renal disease in France. International Journal of Health Care Finance and Economics. DOI:  10.1007/s10754-007-9025-8
  24. Frei, U., & Schober-Halstenberg, H-J. (2002). Annual report on dialysis treatment and renal transplantation in Germany for 2001/2002. Retrieved March 13, 2007, from http://www.quasi-niere.de/berichte/online/en/01/world.htmlGoogle Scholar
  25. Fukuhara, S., Yamazaki, C., Hayashino, Y., Higashi, T., Eichleay, M. A., Akiba, T., Akizawa, T., Saito, A., Port, F. K., & Kurokawa, K. (2007). The organization and financing of end-stage renal disease treatment in Japan. International Journal of Health Care Finance and Economics. DOI:  10.1007/s10754-007-9017-8
  26. Furniss A.L., Young E.W., Gillespie B.W., Akizawa T., Marshall M.R., Saito A., Wikström B., Keen M.L., Pisoni R.L. (2006). Catheter use predicts septicemia/endocarditis events for hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Journal of the American Society of Nephrology, 17, 588AGoogle Scholar
  27. Goodkin D.A., Bragg-Gresham J.L., Koenig K.G., Wolfe R.A., Akiba T., Andreucci V.E., Saito A., Rayner H.C., Kurokawa K., Port F.K., Held P.J., Young E.W. (2003). Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and The United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Journal of the American Society of Nephrology, 14(12): 3270–3277CrossRefGoogle Scholar
  28. Green J., Passman L.J., Wintfeld N. (1991). Analyzing hospital mortality: The consequences of diversity in patient mix. Journal of the American Medical Association, 265, 1849–1853CrossRefGoogle Scholar
  29. Groupement des Nephrologues Francophones de Belgique (GNFB). (2002). Registre de Néphrologie de la Communauté Français de Belgique: Rapport annuel d’activité des Centres no 9—Année 2001. Brussels, Belgium.Google Scholar
  30. Hakim R.M., Wingard R.L., Parker R.A. (1994). Effect of the dialysis membrane in the treatment of patients with acute renal failure. New England Journal of Medicine, 331(20): 1338–1342CrossRefGoogle Scholar
  31. Harris, A. (2007). The organization and funding of the treatment of end-stage renal disease in Australia. International Journal of Health Care Finance and Economics. DOI:  10.1007/s10754-007-9018-7
  32. Hidai H. (2000). Need for an incentive-based reimbursement policy toward quality of care for dialysis care for dialysis patient management. Kidney International, 58, 363–373CrossRefGoogle Scholar
  33. Hirth, R. A. (2007). The organization and financing of dialysis and kidney transplant care in the United States of America. International Journal of Health Care Finance and Economics. DOI:  10.1007/s10754-007-9019-6
  34. Hirth R.A., Tedeschi P.J., Wheeler J.R.C. (2001). Extent and sources of geographic variation in Medicare end-stage renal disease expenditures. American Journal of Kidney Diseases, 38(4): 824–831Google Scholar
  35. Jacquelinet C., Savoye E., Kessler M., Durand D. (2005). Tendances et perspectives de la greffe rénale en France. Bulletin Ėpidémiologique Hebdomadaire, 37–38, 191–192. Retrieved November 6, 2006, at http://www.invs.sante.fr/beh/2005/37_38/beh_37_38_2005.pdfGoogle Scholar
  36. Jha V. (2004). End-stage renal disease in developing countries: The India experience. Renal Failure, 26(3): 201–208CrossRefGoogle Scholar
  37. Japanese Society for Dialysis Therapy (JSDT) (2002). An Overview of Regular Dialysis Treatment in Japan (as of December 31, 2000) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy.Google Scholar
  38. Japanese Society for Dialysis Therapy (JSDT) (2005). An overview of regular dialysis treatment in Japan (as of December 31, 2003) [in Japanese]. Tokyo: Japanese Society for Dialysis Therapy.Google Scholar
  39. Japanese Society for Dialysis Therapy (JSDT) (2006). A review of regular dialysis treatment in Japan (as of December 31, 2004)[in Japanese]. Tokyo: Japanese Society for Dialysis Therapy [CD Rom].Google Scholar
  40. Kimura R. (1998). Organ transplantation and brain-death in Japan: Cultural, legal and bioethical background. Annals of Transplantation, 3(3): 55–58Google Scholar
  41. Kleophas, W., & Reichel, H. (2007). International Study of Health Care Organization and Financing: Development of renal replacement therapy in Germany. International Journal of Health Care Finance and Economics. DOI:  10.1007/s10754-007-9020-0
  42. Laupacis A., Keown P., Pus N., Krueger H., Ferguson B., Wong C.M Muirhead N. (1996). A study of the quality of life and cost-utility of renal transplantation. Kidney International, 50, 235-242CrossRefGoogle Scholar
  43. Lee H., Manns B., Taub K., Ghali W.A., Dean S., Johnson D., Donaldson C. (2002). Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. American Journal of Kidney Diseases, 40(3): 611–622CrossRefGoogle Scholar
  44. Luño, J. (2007). The organization and financing of end-stage renal disease in Spain. International Journal of Health Care Finance and Economics. DOI:  10.1007/s10754-007-9021-z
  45. Macron-Noguès, F., Vernay, M., Ekong, E., Lemaire, N., Salanave, B., Marty, M., Revel, M., Fender, P., & Allemand, H. (2005). La prévalence de l’insuffisance rénale chronique terminale traitée par dialyse en France en 2003: L’enquête nationale Sros-IRCT. Bulletin Ėpidémiologique Hebdomadaire, 37–38, 182–184. Retrieved November 6, 2006, from http://www.invs.sante.fr/beh/2005/37_38/beh_37_38_2005.pdfGoogle Scholar
  46. Mandelbrot, D. (1999). High-flux dialysis. In The kidney transplant/dialysis association patient handbook. Retrieved April 25, 2006, at http://msl1.mit.edu/ESD10/kidneys/HndbkHTML/contents.htmGoogle Scholar
  47. Manns, B. J., Mendelssohn, D. C., & Taub, K. J. (2007). The economics of end-stage renal disease care in Canada: Incentives and impact on delivery of care. International Journal of Health Care Finance and Economics. DOI:  10.1007/s10754-007-9022-y
  48. Mapes, D. L., Bodfish, L. J., Pisoni, R. L., Rayner, H. C., Young, E. W., & Held, P. J. (2001). Predictors of staffing practices in hemodialysis (HD) facilities: Dialysis Outcomes and Practice Patterns Study (DOPPS). Journal of the American Society of Nephrology, 12, 337A.Google Scholar
  49. McNeill, D., & Coonan, C. (2006). Japanese flock to China for organ transplants. Japan Focus. Accessed December 8, 2006, at http://www.japanfocus.org/products/details/1818Google Scholar
  50. Mendelssohn D.C., Kua B.T., Singer P.A. (1995). Referral for dialysis in Ontario. Archives of Internal Medicine, 1555, 2473–2478CrossRefGoogle Scholar
  51. Ministero della Salute, Centro Nazionale Trapianti. Attività donazione e trapianto 2004—dati al 31 dicembre 2004. Retrieved June, 2005, at http://www.ministerosalute.it/trapianti/normativa/statistiche.jspGoogle Scholar
  52. Nakai S., Shinzato T., Sanaka T., Kikuchi K., Kitaoka T., Shinoda T., Yamazaki C., Sakai R., Omori H., Morita O., Iseki K., Kubo K., Tabei K., Masakane I., Fushimi K., Wada A., Miwa N., Akiba T. (2002). The current state of chronic dialysis treatment in Japan (as of December 31, 2000). Journal of the Japan Society of Dialysis Therapy, 35(7): 1155–1184Google Scholar
  53. National Kidney Foundation (2000). Clinical practice guidelines for nutrition in chronic renal failure. Retreived January, 2007, at http://www.kidney.org/professionals/KDOQI/guidelines_updates/doqi_nut.htmlGoogle Scholar
  54. National Kidney Foundation (2006a). K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Retreived January, 2007, at http://www.kidney.org/professionals/KDOQI/guidelines_anemia/index.htmGoogle Scholar
  55. National Kidney Foundation (2006b). Clinical practice guidelines and clinical practice recommendations: 2006 updates for hemodialysis adequacy, peritoneal dialysis adequacy, and vascular access. Accessed January 2007 at http://www.kidney.org/professionals/KDOQI/guideline_upHD_PD_VA/va_guide8.htmGoogle Scholar
  56. NBVN (2002). Annual Report 2002. Edegem, Belgium: Nederlandstalige Belgische Vereniging voor Nefrologie.Google Scholar
  57. Nicholson, T., & Roderick, P. (2007). International Study of Health Care Organization and Financing of Renal Services in England and Wales. International Journal of Health Care Finance and Economics. DOI:  10.1007/s10754-007-9015-x
  58. OECD. (2005). OECD in figures 2005 edition: Health spending and resources. Paris: Organization for Economic Cooperation and Development. Retrieved October, 2006, at http://www.oecd.org/topicstatsportal/ 0,2647, en_2825_495642_2757088_1_1_1_1,00.htmlGoogle Scholar
  59. OECD (2006). Purchasing Power Parities (PPPs) for OECD countries 1980–2005. Paris: Organization for Economic Cooperation and Development. Retrieved October, 2006, at http://www.oecd.org/statisticsdata/0,2643,en_2649_34357_1_119656_1_1_1,00.htmlGoogle Scholar
  60. Pauly M.V. (1993). U.S. health care costs: The untold true story. Health Affairs, 12(3): 152–159CrossRefGoogle Scholar
  61. Pauly M.V., Held P.J. (1990). Benign moral hazard. Journal of Health Economics, 9(4): 447–461CrossRefGoogle Scholar
  62. Pine M., Norusis M., Jones B., Rosenthal G.E. (1997). Predictions of hospital mortality rates: A comparison of data sources. Annals of Internal Medicine, 126(5): 347–354Google Scholar
  63. Pisoni, R. L., Albert, J. M., Elder, S. E., Ethier, J., Kimata, N., Krishnan, M., Rayner, H. C., Saito, A., Sands, J., Saran, R., Wolfe, R. A., & Port, F. K. (2005). Lower mortality risk associated with native arteriovenous fistula (AVF) and graft (AVG) use in patient and facility-level analyses: Results from the DOPPS. Journal of the American Society of Nephrology, 16, 259A.Google Scholar
  64. Pisoni R.L., Gillespie B.W., Dickinson D.M., Chen K., Kutner M., Wolfe R.A. (2004). The Dialysis Outcomes and Practice Patterns Study: Design, data elements, and methodology. American Journal of Kidney Diseases, 44 (Suppl 2): S7–S15CrossRefGoogle Scholar
  65. Pisoni, R. L., Young, E. W., Combe, C., Leavey, S. F., Greenwood, R. N., Hecking, E., Canaud, B. J., & F. (2001). Higher catheter use within facilities is associated with increased mortality and hospitalization: Results from DOPPS. Journal of the American Society of Nephrology, 12, 299A.Google Scholar
  66. Pontoriero, G., Pozzoni, P., Del Vecchio, L., & Locatelli, F. (2007). International Study of Health Care Organization and Financing of renal replacement therapy in Italy: An evolving reality. International Journal of Health Care Finance and Economics. DOI:  10.1007/s10754-007-9016-9
  67. Port F.K., Wolfe R.A., Hulbert-Shearon T.E., McCullough K.P., Ashby V.B., Held P.J. (2004). High dialysis dose is associated with lower mortality among women but not among men. American Journal of Kidney Diseases, 43(6): 1014–1023CrossRefGoogle Scholar
  68. Rayner H.C., Pisoni R.L., Bommer J., Canaud B., Hecking E., Locatelli F., Piera L., Bragg-Gresham J.L., Feldman H.I., Goodkin D.A., Gillespie B., Wolfe R.A., Held P.J., Port F.K. (2004). Mortality and hospitalization in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis Transplantation, 19(1): 108–120CrossRefGoogle Scholar
  69. Saran R., Bragg-Gresham J.L., Levin N.W., Twardowski Z.J., Wizemann V., Saito A., Kimata N., Gillespie B.W., Combe C., Bommer J., Akiba T., Mapes D.L., Young E.W., Port F.K. (2006). Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney International, 69(7): 1222–1228CrossRefGoogle Scholar
  70. Svenskt Register för Aktiv Uremivård (SRAU) (2003). Aktiv uremivård i sverige: 1991–2002. Retrieved February 19, 2007, from http://www.socialstyrelsen.se/NR/rdonlyres/AC1A8C40-F4B8-4297-A24B-E7671B8CC31E/0/kva023r03.pdf.Google Scholar
  71. Szczech L.A., Klassen P.S., Chua B., Hedayati S.S., Flanigan M., McClellan W.M., Reddan D.N., Rettig R.A., Frankenfield D.L., Owen W.F. Jr. (2006). Assocations between CMS’s clinical performance measures project benchmarks, profit structure, and mortality in dialysis units. Kidney International, 69(11): 2094–2100CrossRefGoogle Scholar
  72. TRANSPLANeT (2007). The number of presently registered people. Community Data File, Japan Organ Transplant Network. Retrieved December 8, 2006, at http://translate.google.com/translate?hl=en&sl=ja&u= http://www.jotnw.or.jp/&sa=X&oi=translate&resnum=2&ct=result&prev=/search%3Fq%3Djapan%2 Borgan%2Btransplant%2Bnetwork%26hl%3Den%26lr%3D%26sa%3DGGoogle Scholar
  73. Twardowski Z.J. (2006). Dialyzer reuse—part II: Advantages and disadvantages. Seminars Dialysis, 19(3): 217–226CrossRefGoogle Scholar
  74. U.S. Census Bureau (2006). International data base. Washington, DC: U.S. Census Bureau. Retrieved 18, 2006, at http://www.census.gov/ipc/www/idbnew.htmlGoogle Scholar
  75. USRDS (2005). Annual data report: Atlas of end stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Diseases.Google Scholar
  76. Van Biesen, W., Lameire, N., Peeters, P., & Vanholder, R. (2007). Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease. International Journal of Health Care Finance and Economics. DOI:  10.1007/s10754-007-9013-z
  77. Wennberg, J. E., Fisher, E. S, & Skinner, J. S. (2002). Geography and the debate over Medicare reform. Health Affairs, Supp Web Exclusives, W96–114.Google Scholar
  78. Wikström, B., Fored, M., Eichleay, M. A., & Jacobson, S. H. (2007). The financing and organization of medical care for patients with end-stage renal disease in Sweden. International Journal of Health Care Finance and Economics. DOI:  10.1007/s10754-007-9013-y
  79. Wolfe R.A., Ashby V.B., Milford E.L., Akinlolu O.O., Ettenger R.E., Agodoa L.Y.C., Held P.J., Port F.K. (1999). Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New England Journal of Medicine, 341, 1725–1730CrossRefGoogle Scholar
  80. Wordsworth S., Ludbrook A. (2005). Comparing costing results in across country economic evaluations: The use of technology specific purchasing power parities. Health Economics, 14, 93–99CrossRefGoogle Scholar
  81. World Bank (2004). GNI per capita 2002: Atlas method and PPP. World Development Indicators database. Retrieved April 6, 2007, at http://www.adoptadoctor.org/gni.pdfGoogle Scholar
  82. World Health Organization (2006). WHO Statistical Information System: Life tables for WHO member states. Retrieved December, 2006, at http://www3.who.int/whosis/life/life_tables/life_tables.cfm? path=life,life_tables&language=englishGoogle Scholar
  83. Yoshino M., Kuhlmann M.K., Greenwood R.N., Pisoni R.L., Port F.K., Jager K.J., Homel P., Augustijn H., de Charro F.T., Collart F., Erek E., Finne P., Garcia-Garcia G., Grönhagen-Riska C., Ioannidis G.A., Ivis F., Leivestad T., Løkkegaard H., Lopot F., Jin D.C., Kotanko P., Kramar R., Nakao T., Nandakumar M., Ramirez S., van der Sande F.M., Schön S., Simpson K., Walker R.G., Zaluska W., Levin N.W. (2006). International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. Journal of the American Society of Nephrology, 17, 3510–3519CrossRefGoogle Scholar
  84. Young E.W., Dykstra D.M., Goodkin D.A., Mapes D.L., Wolfe R.A., Held P.J. (2002). Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). International Society of Nephrology, 61, 2266–2271Google Scholar
  85. Young E.W., Goodkin D.A., Mapes D.L., Port F.K., Keen M.L., Chen K., Maroni B.L., Wolfe R.A., Held P.J. (2000). The Dialysis Outcomes and Practice Patterns Study: An international hemodialysis study. Kidney International, 57(Suppl 74): S74–S81CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Avi Dor
    • 1
    Email author
  • Mark V. Pauly
    • 2
  • Margaret A. Eichleay
    • 3
  • Philip J. Held
    • 3
  1. 1.School of Public Health and Health ServicesGeorge Washington UniversityWashingtonUSA
  2. 2.Wharton School of BusinessUniversity of PennsylvaniaPhiladelphiaUSA
  3. 3.Arbor Research Collaborative for HealthAnn ArborUSA

Personalised recommendations